New Cosponsor — Sep 10, 2012
New Cosponsor: Rep. Christopher “Chris” Smith [R-NJ4]
The bill now has 34 cosponsors (26 Democrats, 8 Republicans).
Jun 3, 2011
112th Congress, 2011–2013
This bill was introduced on June 3, 2011, in a previous session of Congress, but was not enacted.
Representative for California's 24th congressional district
Read Text »
Last Updated: Jun 3, 2011
Length: 16 pages
Referred to Committee — Jun 9, 2011
To amend the Public Health Service Act to improve the diagnosis and treatment of hereditary hemorrhagic telangiectasia, and for other purposes.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Jun 9, 2011
The “H.R.” in “H.R. 2123” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
There have been no votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 2123 — 112th Congress: Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011. Retrieved from https://www.govtrack.us/congress/bills/112/hr2123
“H.R. 2123 — 112th Congress: Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011.” www.GovTrack.us. 2011. July 27, 2015 <https://www.govtrack.us/congress/bills/112/hr2123>
|title=H.R. 2123 (112th)
|accessdate=July 27, 2015
|author=112th Congress (2011)
|date=June 3, 2011
|quote=Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011